1. Xu, Xiaowen, Bi, Xinying, Wang, Jing, Li, Lianyong, Wang, Binbin. 2022. Identification of KANSL1 as a novel pathogenic gene for developmental dysplasia of the hip. In Journal of molecular medicine (Berlin, Germany), 100, 1159-1168. doi:10.1007/s00109-022-02220-4. https://pubmed.ncbi.nlm.nih.gov/35727364/
2. Li, Ting, Lu, Dingyi, Yao, Chengcheng, Li, Ailing, Pan, Xin. 2022. Kansl1 haploinsufficiency impairs autophagosome-lysosome fusion and links autophagic dysfunction with Koolen-de Vries syndrome in mice. In Nature communications, 13, 931. doi:10.1038/s41467-022-28613-0. https://pubmed.ncbi.nlm.nih.gov/35177641/
3. Moreno-Igoa, María, Hernández-Charro, Blanca, Bengoa-Alonso, Amaya, Nieva-Echebarria, Beatriz, Ramos-Arroyo, María Antonia. 2015. KANSL1 gene disruption associated with the full clinical spectrum of 17q21.31 microdeletion syndrome. In BMC medical genetics, 16, 68. doi:10.1186/s12881-015-0211-0. https://pubmed.ncbi.nlm.nih.gov/26293599/
4. Molony, Peter, Smith, Adam C, Selvarajah, Shamini, Sakhdari, Ali. 2022. MDS/MPN-Unclassifiable with t(X;17)(q28;q21) and KANSL1-MTCP1/CMC4 Fusion Gene. In Cytogenetic and genome research, 161, 564-568. doi:10.1159/000521509. https://pubmed.ncbi.nlm.nih.gov/35038703/
5. Fejzo, Marlena S, Chen, Hsiao-Wang, Anderson, Lee, Konecny, Gottfried E, Slamon, Dennis J. 2020. Analysis in epithelial ovarian cancer identifies KANSL1 as a biomarker and target gene for immune response and HDAC inhibition. In Gynecologic oncology, 160, 539-546. doi:10.1016/j.ygyno.2020.11.008. https://pubmed.ncbi.nlm.nih.gov/33229045/
6. Chang, Soojeong, Yim, Sujin, Park, Hyunsung. 2019. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism. In Experimental & molecular medicine, 51, 1-17. doi:10.1038/s12276-019-0230-6. https://pubmed.ncbi.nlm.nih.gov/31221981/
智鼠故事 
